The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions

被引:34
作者
Katz, E [1 ]
Wolffe, EJ [1 ]
Moss, B [1 ]
机构
[1] NIAID,VIRAL DIS LAB,NIH,BETHESDA,MD 20892
关键词
D O I
10.1128/JVI.71.4.3178-3187.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The outer envelope of the extracellular form of vaccinia virus (EEV) is derived from the Golgi membrane and contains at least six viral proteins. Transfection studies indicated that the EEV protein encoded by the B5R gene associates with Golgi membranes when synthesized in the absence of other viral products, a domain swapping strategy was then used to investigate the possibility that the B5R protein contains an EEV targeting signal. We constructed chimeric genes encoding the human immunodeficiency virus (HIV) type 1 glycoprotein with the cytoplasmic and transmembrane domains replaced by the corresponding 42-amino-acid C-terminal segment of the B5R protein. Recombinant vaccinia viruses that stably express a chimeric B5R-HIV protein or a control HIV envelope protein with the original cytoplasmic and transmembrane domains were isolated. Cells infected with recombinant vaccinia viruses that expressed either the unmodified or the chimeric HIV envelope protein formed syncytia with cells expressing the CD4 receptor for HIV. However, biochemical and microscopic studies demonstrated that the HIV envelope proteins with the B5R cytoplasmic and transmembrane domains were preferentially targeted to the EEV. These data are consistent with the presence of EEV localization signals in the cytoplasmic and transmembrane domains of the B5R protein.
引用
收藏
页码:3178 / 3187
页数:10
相关论文
共 66 条
[1]   HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEIN CD4-MEDIATED FUSION OF NONPRIMATE CELLS WITH HUMAN-CELLS [J].
ASHORN, PA ;
BERGER, EA ;
MOSS, B .
JOURNAL OF VIROLOGY, 1990, 64 (05) :2149-2156
[2]   DISSOCIATION OF PROGENY VACCINIA VIRUS FROM THE CELL-MEMBRANE IS REGULATED BY A VIRAL ENVELOPE GLYCOPROTEIN - EFFECT OF A POINT MUTATION IN THE LECTIN HOMOLOGY DOMAIN OF THE A34R GENE [J].
BLASCO, R ;
SISLER, JR ;
MOSS, B .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3319-3325
[3]   ROLE OF CELL-ASSOCIATED ENVELOPED VACCINIA VIRUS IN CELL-TO-CELL SPREAD [J].
BLASCO, R ;
MOSS, B .
JOURNAL OF VIROLOGY, 1992, 66 (07) :4170-4179
[4]   EXTRACELLULAR VACCINIA VIRUS FORMATION AND CELL-TO-CELL VIRUS TRANSMISSION ARE PREVENTED BY DELETION OF THE GENE ENCODING THE 37,000-DALTON OUTER ENVELOPE PROTEIN [J].
BLASCO, R ;
MOSS, B .
JOURNAL OF VIROLOGY, 1991, 65 (11) :5910-5920
[5]   THE BLOCK TO HIV-1 ENVELOPE GLYCOPROTEIN-MEDIATED MEMBRANE-FUSION IN ANIMAL-CELLS EXPRESSING HUMAN CD4 CAN BE OVERCOME BY A HUMAN CELL COMPONENT(S) [J].
BRODER, CC ;
DIMITROV, DS ;
BLUMENTHAL, R ;
BERGER, EA .
VIROLOGY, 1993, 193 (01) :483-491
[6]   MOLECULAR CHARACTERIZATION OF THE VACCINIA VIRUS HEMAGGLUTININ GENE [J].
BROWN, CK ;
TURNER, PC ;
MOYER, RW .
JOURNAL OF VIROLOGY, 1991, 65 (07) :3598-3606
[7]   VACCINIA VIRUS EXPRESSION VECTOR - COEXPRESSION OF BETA-GALACTOSIDASE PROVIDES VISUAL SCREENING OF RECOMBINANT VIRUS PLAQUES [J].
CHAKRABARTI, S ;
BRECHLING, K ;
MOSS, B .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) :3403-3409
[8]   EXPRESSION OF THE HTLV-III ENVELOPE GENE BY A RECOMBINANT VACCINIA VIRUS [J].
CHAKRABARTI, S ;
ROBERTGUROFF, M ;
WONGSTAAL, F ;
GALLO, RC ;
MOSS, B .
NATURE, 1986, 320 (6062) :535-537
[9]   SAFETY OF AND IMMUNOLOGICAL RESPONSE TO A RECOMBINANT VACCINIA VIRUS-VACCINE EXPRESSING HIV ENVELOPE GLYCOPROTEIN [J].
COONEY, EL ;
COLLIER, AC ;
GREENBERG, PD ;
COOMBS, RW ;
ZARLING, J ;
ARDITTI, DE ;
HOFFMAN, MC ;
HU, SL ;
COREY, L .
LANCET, 1991, 337 (8741) :567-572
[10]   ACTIN-BASED MOTILITY OF VACCINIA VIRUS [J].
CUDMORE, S ;
COSSART, P ;
GRIFFITHS, G ;
WAY, M .
NATURE, 1995, 378 (6557) :636-638